Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 5.442
Filter
1.
BMJ Case Rep ; 17(5)2024 May 10.
Article in English | MEDLINE | ID: mdl-38729657

ABSTRACT

Cat-scratch disease is a zoonosis caused by Bartonella henselae, characterised by regional lymphadenopathy. Rarer presentations, such as osteomyelitis, can occur.We present an adolescent girl with severe right lumbar pain and fever, without animal contacts or recent travels. On examination, pain on flexion of torso, movement limitation and marked lordosis were noted, but there were no inflammatory signs, palpable masses or lymph nodes. Serological investigations revealed elevated inflammatory markers. Imaging revealed a paravertebral abscess with bone erosion. Several microbiological agents were ruled out. After a second CT-guided biopsy, PCR for Bartonella spp was positive. At this point, the family recalled having a young cat some time before. Cat-scratch disease was diagnosed, and complete recovery achieved after treatment with doxycycline and rifampicin.Cat-scratch disease is a challenging diagnosis in the absence of typical features. However, B. henselae must be investigated if common pathogens are ruled out and response to therapy is poor.


Subject(s)
Anti-Bacterial Agents , Bartonella henselae , Cat-Scratch Disease , Osteomyelitis , Cat-Scratch Disease/diagnosis , Cat-Scratch Disease/drug therapy , Cat-Scratch Disease/complications , Humans , Female , Osteomyelitis/microbiology , Osteomyelitis/diagnosis , Osteomyelitis/drug therapy , Osteomyelitis/etiology , Bartonella henselae/isolation & purification , Anti-Bacterial Agents/therapeutic use , Adolescent , Doxycycline/therapeutic use , Rifampin/therapeutic use , Cats , Animals , Tomography, X-Ray Computed
3.
Ticks Tick Borne Dis ; 15(4): 102347, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38714072

ABSTRACT

We report the case of a traveler who returned from Zambia and was diagnosed with Mediterranean spotted fever (MSF), an infectious disease caused by Rickettsia conorii conorii. The patient presented to Sapporo City General Hospital with symptoms of fever, malaise, headache, and rash. The pathogen was identified by Polymerase Chain Reaction assays and subsequent analyses. The patient improved with 10-day treatment of oral doxycycline. Although some cases of MSF have been reported in sub-Saharan Africa, none have been reported in Zambia. Rhipicephalus sanguineus sensu lato, the vector of the Rickettsia conorii conorii, has been found in various areas of Zambia. Our case report highlights the potential threat of Mediterranean spotted fever in urban areas of Zambia.


Subject(s)
Anti-Bacterial Agents , Boutonneuse Fever , Doxycycline , Rickettsia conorii , Zambia , Humans , Doxycycline/therapeutic use , Boutonneuse Fever/drug therapy , Boutonneuse Fever/microbiology , Boutonneuse Fever/diagnosis , Rickettsia conorii/isolation & purification , Rickettsia conorii/genetics , Anti-Bacterial Agents/therapeutic use , Male , Travel , Animals , Adult , Rhipicephalus sanguineus/microbiology
4.
Sex Health ; 212024 May.
Article in English | MEDLINE | ID: mdl-38739741

ABSTRACT

Background We investigated awareness and use of doxycycline post-exposure prophylaxis (doxyPEP) in the US. DoxyPEP has preventative benefits for bacterial STIs among people assigned male at birth. We considered how individual, interpersonal and social determinants of health, such as state-level LGBTQ equality, impact doxyPEP awareness. Methods We conducted an online snapshot cross-sectional survey in June 2023. Survey questions included demographics, sexual and substance use behaviours, and socio-environmental factors, and provided a short explanation of doxyPEP, with questions regarding prior awareness and use. Results Among a racially diverse sample of 196 participants (median age 33 years), 94% identified as cisgender men, 26% were aware of doxyPEP, whereas only 14 (7%) had ever used it. Factors significantly associated with awareness included being college educated (OR 2.50, 95% CI 1.09-5.74), a past year bacterial STI (OR 4.20, 95% CI 1.97-8.89), having discussed HIV pre-exposure prophylaxis with a health care provider (OR 3.88, 95% CI 1.99-7.57) and having taken HIV pre-exposure prophylaxis (OR 2.29, 95% CI 1.11-4.70). Socio-environmental factors associated with doxyPEP awareness included living in a large urban city (OR 2.14, 95% CI 1.12-4.10) and living in a state with higher levels of LGBTQ policy equality (OR 2.18, 95% CI 1.07-4.44). Conclusions Considering the disproportionate impact of bacterial STIs on men who have sex with men, especially those living in lower LGBTQ equality regions, such as the Southern US, our study emphasises how socio-environmental factors may limit awareness and uptake of novel biomedical approaches that have the potential to prevent morbidity and enhance sexual health.


Subject(s)
Doxycycline , Health Knowledge, Attitudes, Practice , Post-Exposure Prophylaxis , Humans , Cross-Sectional Studies , Male , Adult , Doxycycline/therapeutic use , Female , United States , Anti-Bacterial Agents/administration & dosage , Sexual and Gender Minorities/psychology , Young Adult , Surveys and Questionnaires , Middle Aged
5.
Front Public Health ; 12: 1321123, 2024.
Article in English | MEDLINE | ID: mdl-38784570

ABSTRACT

Background: Scrub typhus, caused by the Orientia tsutsugamushi (Ot), is a widespread vector-borne disease transmitted by chigger mites. Hemophagocytic lymphohistiocytosis (HLH) is considered to be one of the potentially severe complications. The diagnosis of scrub typhus-associated HLH may be overlooked due to the non-specific clinical characteristics and the absence of pathognomonic eschar. Case presentation: We obtained clinical data from two patients in the South of Sichuan, China. The first case involved a 6-year-old girl who exhibited an unexplained fever and was initially diagnosed with sepsis, HLH, and pulmonary infection. The other patient presented a more severe condition characterized by multiple organ dysfunction and was initially diagnosed with septic shock, sepsis, HLH, acute kidney injury (AKI), and pulmonary infection. At first, a specific examination for scrub typhus was not performed due to the absence of a characteristic eschar. Conventional peripheral blood cultures yielded negative results in both patients, and neither of them responded to routine antibiotics. Fortunately, the causative pathogen Orientia tsutsugamushi (Ot) was detected in the plasma samples of both patients using metagenomics next-generation sequencing (mNGS) and further confirmed by polymerase chain reaction. Subsequently, they both were treated with doxycycline and recovered quickly. Conclusion: The unbiased mNGS provided a clinically actionable diagnosis for an uncommon pathogen-associated infectious disease that had previously evaded conventional diagnostic approaches.


Subject(s)
Lymphohistiocytosis, Hemophagocytic , Orientia tsutsugamushi , Scrub Typhus , Scrub Typhus/diagnosis , Scrub Typhus/complications , Humans , Female , Child , Orientia tsutsugamushi/isolation & purification , Orientia tsutsugamushi/genetics , Lymphohistiocytosis, Hemophagocytic/diagnosis , China , Male , Doxycycline/therapeutic use
7.
Syst Rev ; 13(1): 108, 2024 Apr 16.
Article in English | MEDLINE | ID: mdl-38627798

ABSTRACT

BACKGROUND: Leptospirosis, an important zoonotic bacterial disease, commonly affects resource-poor populations and results in significant morbidity and mortality worldwide. The value of antibiotics in leptospirosis remains unclear, as evidenced by the conflicting opinions published. METHODS: We conducted a search in the PubMed, Web of Science, and Cochrane Library databases for studies. These studies included clinical trials and retrospective studies that evaluated the efficacy or safety of antibiotics for leptospirosis treatment. The primary outcomes assessed were defervescence time, mortality rate, and hospital stays. Subgroup analyses were performed based on whether there were cases involving children and whether there were cases of severe jaundice. Safety was defined as the prevalence of adverse events associated with the use of antibiotics. p scores were utilized to rank the efficacy of the antibiotics. RESULTS: There are included 9 randomized controlled trials (RCTs), 1 control trial (CT), and 3 retrospective studies (RS) involving 920 patients and 8 antibiotics. Six antibiotics resulted in significantly shorter defervescence times compared to the control, namely cefotaxime (MD, - 1.88; 95% CI = - 2.60 to - 1.15), azithromycin (MD, - 1.74; 95% CI = - 2.52 to - 0.95), doxycycline (MD, - 1.53; 95% CI = - 2.05 to - 1.00), ceftriaxone (MD, - 1.22; 95% CI = - 1.89 to - 0.55), penicillin (MD, - 1.22; 95% CI = - 1.80 to - 0.64), and penicillin or ampicillin (MD, - 0.08; 95% CI = - 1.01 to - 0.59). The antibiotics were not effective in reducing the mortality and hospital stays. Common adverse reactions to antibiotics included Jarisch-Herxheimer reaction, rash, headache, and digestive reactions (nausea, vomiting, diarrhea, abdominal pain, and others). CONCLUSIONS: Findings recommend that leptospirosis patients be treated with antibiotics, which significantly reduced the leptospirosis defervescence time. Cephalosporins, doxycycline, and penicillin are suggested, and azithromycin may be a suitable alternative for drug-resistant cases. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022354938.


Subject(s)
Anti-Bacterial Agents , Leptospirosis , Humans , Anti-Bacterial Agents/adverse effects , Azithromycin/adverse effects , Doxycycline/therapeutic use , Leptospirosis/drug therapy , Leptospirosis/chemically induced , Network Meta-Analysis , Penicillins/therapeutic use
8.
AIDS Patient Care STDS ; 38(4): 155-167, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38656217

ABSTRACT

Doxycycline postexposure prophylaxis (doxy-PEP) reduces sexually transmitted infections (STIs) in men who have sex with men (MSM) and transgender women (TGW). In a clinical trial of doxy-PEP, we sought to assess acceptability, impact, and meaning of doxy-PEP use among MSM/TGW. We conducted semistructured, in-depth 1:1 interviews with MSM and TGW enrolled in the intervention arm of the Doxy-PEP study. We queried motivations for and meaning of use, attitudes, beliefs, adherence, effect on sexual behaviors, and partner, community, and structural factors related to use. We coded interview transcripts into content areas, followed by thematic analysis. We interviewed 44 participants (median age 38), 2% were TGW, 17% Black, 61% White, 30% Hispanic, and 45% persons with HIV. We identified three overarching themes. First, participants found doxy-PEP acceptable, and believed it was effective based on their history of STIs, easy to adhere to, and acceptable to sex partners. Second, doxy-PEP benefited their quality of life and mental health, offering "peace of mind" by reducing their anxiety about acquisition or unwitting transmission of STIs. Participants reported feeling more "in control" of preventing STIs, and positive about supporting their personal, partner, and community health. Third, impact on sexual behavior was variable, with most reporting no change or a brief initial change. Participants in a multi-site clinical trial of doxycycline for STI prevention perceived it to be efficacious, and that it provided quality-of-life benefits, including reduced anxiety and sense of control over sexual health. Doxy-PEP had limited impact on sexual behavior. Clinicaltrials.gov: NCT03980223.


Subject(s)
Doxycycline , Homosexuality, Male , Post-Exposure Prophylaxis , Sexual Behavior , Sexual Partners , Sexually Transmitted Diseases , Transgender Persons , Adult , Female , Humans , Male , Middle Aged , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Doxycycline/administration & dosage , Doxycycline/therapeutic use , Health Knowledge, Attitudes, Practice , HIV Infections/prevention & control , HIV Infections/psychology , Homosexuality, Male/psychology , Interviews as Topic , Patient Acceptance of Health Care/psychology , Patient Acceptance of Health Care/statistics & numerical data , Qualitative Research , Sexual Behavior/psychology , Sexual Health , Sexual Partners/psychology , Sexually Transmitted Diseases/prevention & control , Transgender Persons/psychology
10.
Vaccine ; 42(13): 3220-3229, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38641497

ABSTRACT

Leptospirosis, a globally significant zoonotic disease caused by pathogenic Leptospira, continues to threaten the health and public safety of both humans and animals. Current clinical treatment of leptospirosis mainly relies on antibiotics but their efficacy in severe cases is controversial. Passive immunization has a protective effect in the treatment of infectious diseases. In addition, chicken egg yolk antibody (IgY) has gained increasing attention as a safe passive immunization agent. This study aimed to investigate whether hens produce specific IgY after immunization with inactivated Leptospira and the protective effect of specific IgY against leptospirosis. First, it was demonstrated that specific IgY could be extracted from the eggs of hens vaccinated with inactivated Leptospira and that specific IgY can specifically recognize and bind homotypic Leptospira with a high titre, as shown by MAT and ELISA. Next, we tested the therapeutic effects of IgY in early and late leptospirosis using a hamster model. The results showed that early specific IgY treatment increased the survival rate of hamsters to 100%, alleviated pathological damage to the liver, kidney, and lung, reduced leptospiral burden, and restored haematological indices as well as functional indicators of the liver and kidney. The therapeutic effect of early specific IgY was comparable to that of doxycycline. Late IgY treatment also enhanced the survival rate of hamsters and improved the symptoms of leptospirosis similar to early IgY treatment. However, the therapeutic effect of late IgY treatment was better when combined with doxycycline. Furthermore, no Leptospira colonization was observed in the kidneys, livers, or lungs of the surviving hamsters treated with specific IgY. Mechanistically, IgY was found to inhibit the growth and adhesion to cells of Leptospira. In conclusion, passive immunotherapy with specific IgY can be considered an effective treatment for leptospirosis, and may replace antibiotics regarding its therapeutic effects.


Subject(s)
Antibodies, Bacterial , Immunization, Passive , Immunoglobulins , Leptospira , Leptospirosis , Animals , Cricetinae , Female , Antibodies, Bacterial/immunology , Chickens/immunology , Disease Models, Animal , Doxycycline/therapeutic use , Doxycycline/administration & dosage , Doxycycline/pharmacology , Egg Yolk/immunology , Immunization, Passive/methods , Immunoglobulins/immunology , Immunoglobulins/administration & dosage , Kidney/pathology , Kidney/immunology , Kidney/microbiology , Leptospira/immunology , Leptospirosis/immunology , Leptospirosis/prevention & control , Leptospirosis/therapy , Liver/immunology , Liver/pathology , Liver/microbiology , Mesocricetus , Vaccines, Inactivated/immunology , Vaccines, Inactivated/administration & dosage
13.
Gen Dent ; 72(3): 70-73, 2024.
Article in English | MEDLINE | ID: mdl-38640010

ABSTRACT

Treatment of peri-implant diseases focuses on reducing the bacterial load and consequent infection control. The use of local antimicrobials as an adjunct to mechanical therapy may result in a better outcome. Among antimicrobials, doxycycline stands out because of its local modulation of cytokines, microbial reduction, and clinical parameters in the treatment of periodontal diseases. The objective of this case report was to describe the combined application of mechanical debridement and bioresorbable doxycycline-loaded nanospheres for the treatment of peri-implantitis in a 71-year-old man. At the 3-year evaluation, the peri-implant tissues had improved, showing decreased probing depths, an absence of bleeding on probing, and no suppuration. This case report highlights the importance of supportive therapy, which is essential for the long-term success of peri-implantitis treatment.


Subject(s)
Anti-Infective Agents , Dental Implants , Nanospheres , Peri-Implantitis , Male , Humans , Aged , Peri-Implantitis/drug therapy , Peri-Implantitis/microbiology , Doxycycline/therapeutic use , Follow-Up Studies , Debridement , Absorbable Implants , Anti-Infective Agents/therapeutic use , Treatment Outcome
15.
Front Cell Infect Microbiol ; 14: 1323054, 2024.
Article in English | MEDLINE | ID: mdl-38567022

ABSTRACT

The patient, a 43-year-old male, was admitted to the hospital with gradually aggravated exertional palpitations and chest tightness over a 2-day period. Upon hospital admission, a cardiac ultrasound revealed aortic valve redundancy, however multiple blood culture investigations came back negative. Blood mNGS was perfected, revealing Coxiella burnetii, and the diagnosis of Q fever (query fever) was established. The temperature and inflammatory indices of the patient were all normal with the treatment of vancomycin before cardiac surgery. But for the potential liver damage of and the Coxiella burnetii was still positive in the anti-phase II IgG titer, the doxycycline and hydroxychloroquine instead of vancomycin were applied for the patient. Despite receiving standardized anti-infective therapy of doxycycline combined with hydroxychloroquine, this patient had fever and increased leukocytes following surgery. After the addition of vancomycin as an anti-infective treatment, the temperature and leukocytes improved quickly. During the treatment of vancomycin, a discovery of liver injury may have resulted. These findings provide new therapy options for future professionals.


Subject(s)
Coxiella burnetii , Endocarditis, Bacterial , Q Fever , Male , Humans , Adult , Q Fever/diagnosis , Q Fever/drug therapy , Vancomycin/therapeutic use , Doxycycline/therapeutic use , Hydroxychloroquine , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/drug therapy
16.
Ital J Pediatr ; 50(1): 38, 2024 Mar 05.
Article in English | MEDLINE | ID: mdl-38439015

ABSTRACT

BACKGROUND: The prevalence of macrolide-resistant Mycoplasma pneumoniae has increased considerably. Treatment in children has become challenging. This study aimed to evaluate the efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods. METHODS: We retrospectively analyzed the data of patients with macrolide-resistant Mycoplasma pneumoniae pneumonia hospitalized between May 2019 to August 2022. According to treatment, patients were divided into three groups: oral doxycycline treatment alone (DOX group), changed from intravenous azithromycin to oral doxycycline (ATD group), and intravenous azithromycin treatment alone (AZI group). ATD group cases were separated into two sub-groups: intravenous azithromycin treatment<3 days (ATD1 group) and ≥ 3 days (ATD2 group). Clinical symptoms were compared in each group and adjusted by Propensity score matching (PSM) analysis. RESULTS: A total of 106 were recruited in this study. 17 (16%) were in DOX group, 58 (55%) in ATD group, and 31(29%) in AZI group. Compared with ATD group and AZI group, the DOX group showed shorter hospitalization duration and fever duration after treatment, while higher rate of chest radiographic improvement. After using PSM analysis, shorter days to hospitalization duration (P = 0.037) and to fever duration after treatment (P = 0.027) in DOX + ATD1 group than in ATD2 group was observed. A higher number of patients in the DOX + ATD1 group achieved defervescence within 72 h (P = 0.031), and fewer children received glucocorticoid adjuvant therapy (P = 0.002). No adverse reactions associated with doxycycline was observed during treatment. CONCLUSIONS: Children receiving early oral doxycycline had a shorter duration of fever and hospitalization in macrolide-resistant Mycoplasma pneumoniae patients.


Subject(s)
Doxycycline , Pneumonia, Mycoplasma , Child , Humans , Doxycycline/therapeutic use , Mycoplasma pneumoniae , Macrolides/therapeutic use , Azithromycin , Retrospective Studies , Anti-Bacterial Agents/therapeutic use , Pneumonia, Mycoplasma/drug therapy
17.
J Dermatolog Treat ; 35(1): 2329248, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38479408

ABSTRACT

Background: Pyoderma vegetans (PV) is a rare neutrophilic dermatosis of unknown etiology. Currently, there are no treatment guidelines for PV. Systemic steroids are often used as first-line therapy, but recurrence upon discontinuation or tapering is common.Materials and methods: We tested the efficacy of doxycycline at a dose of 200 mg/d to treat resistant PV.Results: After 4 weeks of treatment we noticed a significant improvement in the clinical appearance of PV.Conclusions: Our case demonstrates the potential utility of doxycycline as a systemic steroid-sparing agent in the treatment of PV.


Subject(s)
Pemphigus , Pyoderma Gangrenosum , Pyoderma , Skin Diseases, Bacterial , Humans , Doxycycline/therapeutic use , Pyoderma/drug therapy , Pyoderma/etiology , Organic Chemicals
18.
PLoS One ; 19(3): e0299878, 2024.
Article in English | MEDLINE | ID: mdl-38536847

ABSTRACT

OBJECTIVE: To evaluate the outcome of complicated osteoarticular brucellosis. METHODS: A retrospective chart review was conducted at King Abdulaziz Medical City (KAMC), in Riyadh, Saudi Arabia. All patients aged more than 14 who have been diagnosed with complicated brucellosis with osteoarticular disease between July 2016 and December 2022 were included. RESULTS: A total of 82 (10.7%) patients met the criteria, with a male predominance of 66 (80.4%), and their mean age was 56.4 ± 19.3 years. A positive blood culture was found in 33 (40.2%). The most common clinical presentation was fever (57.3%). All patients received a doxycycline-based regimen except one. 62 (75.60%) patients were treated with three or more medication regimens, while 20 (24.40%) patients received two drug regimens. The mean duration of therapy was 94.2 days for two-drug therapy and 116.4 days for three-drug therapy. A total of 78 out of 82 (95.1%) cases were cured at the end of treatment. Unfavorable outcomes were documented in four cases (two relapses and two treatment failures). Neither using three drugs regimen nor longer duration of therapy was associated with better outcome. CONCLUSIONS: Unfavorable outcomes have been noticed to be minimal in our cohort of patients with osteoarticular brucellosis, treated mainly with a three-drug regimen and a longer duration of therapy.


Subject(s)
Brucellosis , Humans , Male , Adult , Middle Aged , Aged , Female , Retrospective Studies , Saudi Arabia/epidemiology , Tertiary Care Centers , Brucellosis/complications , Brucellosis/drug therapy , Brucellosis/diagnosis , Doxycycline/therapeutic use
19.
J Antimicrob Chemother ; 79(5): 1060-1068, 2024 May 02.
Article in English | MEDLINE | ID: mdl-38517444

ABSTRACT

BACKGROUND: Antimicrobial resistance in Neisseria gonorrhoeae is a global public health concern. Tetracycline resistance (TetR) increased from 39.4% to 75.2% between 2016 and 2021 in N. gonorrhoeae isolates collected through national surveillance in England, despite the absence of use of tetracyclines for the treatment of gonorrhoea. OBJECTIVES: We investigated whether there was correlation between bacterial sexually transmitted infection (STI) tests performed and treatment with antimicrobials, with increased TetR in N. gonorrhoeae. METHODS: We examined correlations between bacterial STI tests, antimicrobial treatment and TetR in N. gonorrhoeae, using national surveillance data from three large sexual health services (SHS) in London during 2016-20. Doxycycline prescribing data and antibiograms of a non-STI pathogen from distinct patient groups (sexual health, obstetric and paediatric), at a large London hospital, were analysed to identify if doxycycline use in SHS was associated with resistance in a non-STI organism. RESULTS: A substantial increase in TetR was observed, particularly in isolates from gay, bisexual and other MSM (GBMSM). Strong positive correlations were observed exclusively in GBMSM between N. gonorrhoeae TetR and both bacterial STI tests (r = 0.97, P = 0.01) and antimicrobial treatment (r = 0.87, P = 0.05). Doxycycline prescribing increased dramatically during the study period in SHS. Prevalence of TetR in Staphylococcus aureus was higher in isolates sourced from SHS attendees than those from other settings. CONCLUSIONS: Frequent screening of GBMSM at higher risk of STIs, such as those on pre-exposure prophylaxis (PrEP) leading to/and increased use of doxycycline for the treatment of diagnosed infections, may account for the increase in TetR in N. gonorrhoeae.


Subject(s)
Anti-Bacterial Agents , Doxycycline , Gonorrhea , Microbial Sensitivity Tests , Neisseria gonorrhoeae , Tetracycline Resistance , Neisseria gonorrhoeae/drug effects , Neisseria gonorrhoeae/isolation & purification , Humans , Gonorrhea/microbiology , Gonorrhea/epidemiology , Gonorrhea/drug therapy , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , England/epidemiology , Male , Female , Doxycycline/therapeutic use , Doxycycline/pharmacology , Adult , London/epidemiology , Tetracycline/pharmacology , Tetracycline/therapeutic use
20.
Inn Med (Heidelb) ; 65(5): 512-516, 2024 May.
Article in German | MEDLINE | ID: mdl-38459199

ABSTRACT

BACKGROUND: Rat bite fever is a rare but potentially fatal bacterial zoonosis. The symptoms can be unspecific, but severe sepsis can be associated with involvement of different organs. CASE REPORT: A 27-year-old homeless man presented with fever, suspected meningitis, acute renal failure, unclear skin lesions as well as joint problems and muscular pain. Bite wounds were not detected. Meningitis could be excluded after lumbar puncture, and there was no evidence of endocarditis as the cause of the skin lesions. After 72 h, growth of Streptobacillus moniliformis in blood cultures was detected. Clinical symptoms were compatible with the diagnosis of rat bite fever. Calculated antibiosis with ampicillin sulbactam and doxycycline led to regression of the symptoms. CONCLUSION: Rat bite fever poses a diagnostic challenge due unspecific symptoms, diverse differential diagnostic options, and challenging microbiological detection. Patient history is of the utmost importance. Due to the rarity of the disease, this case report is intended to raise awareness.


Subject(s)
Rat-Bite Fever , Streptobacillus , Zoonoses , Male , Adult , Rat-Bite Fever/diagnosis , Rat-Bite Fever/drug therapy , Rat-Bite Fever/microbiology , Humans , Animals , Streptobacillus/isolation & purification , Zoonoses/diagnosis , Zoonoses/microbiology , Zoonoses/transmission , Anti-Bacterial Agents/therapeutic use , Doxycycline/therapeutic use , Diagnosis, Differential , Rats , Sulbactam/therapeutic use , Sulbactam/administration & dosage , Ampicillin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...